AN/BN Risk Factors Study

NCT ID: NCT05133037

Last Updated: 2025-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-23

Study Completion Date

2029-05-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Across the United States, thousands of children and adolescents suffer from eating disorders. Among young women alone, an estimated 2 to 4 percent are dealing with anorexia nervosa. Anorexia nervosa also has the highest mortality rate of any psychiatric disorder and produces a six-fold increased risk for death. Unfortunately, study shows that current treatments are only successful with 25 percent of patients and no eating disorder prevention program has been found to reduce future onset of anorexia nervosa. The goal of this study is to conduct a highly innovative pilot study that will identify risk factors that predict future onset of anorexia nervosa and investigate how the risk processes for anorexia nervosa are different from the risk processes for bulimia nervosa. The proposed pilot study will:

* Compare 30 healthy adolescent girls at high risk for anorexia nervosa to 30 healthy adolescent girls at high risk for bulimia nervosa, and 30 healthy adolescent girls at low risk for eating disorder in an effort to document risk processes that are present in early adolescence before anorexia nervosa typically emerges.
* Test whether elevations in the hypothesized risk factors predict future onset of anorexia nervosa over a four-year follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Data verification, preliminary analyses, and missing data. Data will be entered twice and discrepancies corrected. Preliminary analyses will examine out-of-range values or unusual distributions. Reaction time data that are +/-2 SD from the mean will be excluded from analyses, following convention. All data will be analyzed regardless of missing follow-up data. Missing data will be addressed using maximum likelihood estimation, multiple imputation, or Type I and random right censoring. Maximum likelihood procedures, as well as multiple imputation, can provide unbiased estimates even in instances of substantial attrition (Shafer \& Graham, 2002). Multiple imputation procedures will follow best-practice recommendations (Graham et al., 2007) and missing values will be imputed using the mice package in R (van Buuren \& Groothuis-Oudshoorn, 2011). Observed and imputed datasets will be compared to ensure they show similar distributions and will be analyzed separately and results combined to obtain inferential tests based on average parameter estimates and standard errors (Rubin, 2009).

Image processing. MR scans will be performed with a 3T GE MR 750 scanner system. Blood oxygen-level dependent, echo-planar images (BOLD-EPI) will be acquired with T2\*-weighted multiband (simultaneous multi-slice) acquisition sequence (TR=2000ms, TE=30ms, flip angle=53, multiband factor=4, 2.2mm isotropic voxel size; 64 8x8 axial slices with no gap). Slices will be tilted \~30 degrees relative to the AC-PC line. A rear-projection system will present visual stimuli and a button box will assess behavioral responses. Timing and delivery of the experimental tasks to the stimulus display equipment will be controlled via a MacBook Pro using Psychtoolbox software run on MATLAB. Data analysis will be performed primarily using Statistical Parametric Mapping 12 (SPM12). We will either rescan participants for whom we have poor data or recruit a replacement. Preprocessing will include rigid-body transformation (realignment) and coregistration to the first functional image of each run. Images within each run will be aligned to the first image of that run, and then aligned to the first image from the first run, using a 6-parameter rigid body algorithm in SPM12. The MP-RAGE scan will then be skull-stripped (with FSL's brain extraction tool) and normalized to a high-resolution, T1-weighted template yielding a set of normalization parameters. Parameters will then be applied to all functional and anatomical images, which will then be smoothed with a 6-mm smoothing kernel. We considered using age-specific brain template (Wilke et al., 2003), however, use in analyses with adolescents did not improve data quality. Statistical comparisons will be computed using a general linear model in SPM12 at the subject level, then imported to second level random effects models. A Monte Carlo simulation using true smoothness will be used to compute voxel-wise and cluster-size thresholds for our data that adjust for multiple comparisons to achieve a family-wise Type I error rate of 5%.We will control for hunger and menstrual phase. We will correct fMRI scans for motion, scanner, and cerebrospinal fluid artifacts using independent component analysis (ICA) denoising (Kelly et al., 2010). We will use Artifact Detection Toolbox (ART; Gabrieli Laboratory, McGovern Institute for Brain Research, Cambridge MA) to detect spikes in global mean response and motion outliers in the functional data. Motion parameters will be included as regressors in the design matrix at individual-level analysis. To identify brain regions activated in response to exposure to thin women and high-calorie foods, we will contrast fMRI BOLD response during the presentation of thin women/high-calorie food images versus images of average-weight women/glasses of water.To identify brain regions activated in response to food receipt we will contrast BOLD response during receipt of milkshake verses tasteless solution. To identify brain regions activated in response to anticipated milkshake receipt we will contrast BOLD response during the cue for impending milkshake receipt versus the cue for impending tasteless solution receipt. To identify brain activation in response to inhibitory control to high-calorie foods, we will contrast successfully inhibited response to no-go dessert trials versus no-go vegetable trials.

For the delay discounting task, the rate at which the subjective value of a reward decays with delay (TD rate) will be assessed through Mazur's (1987) equation: Vd = V/ (1+kD), where Vd represents the discounted value at D delay, V is the undiscounted amounted, and k is the estimated discounted parameter. High values of k indicate a preference for immediate rewards. Vd will be derived by calculating individuals' indifference point -the value of the immediate snack reward that is considered as attractive as the 40 units delayed snack reward. Indifference points will be calculated for each delay and fit to the hyperbolic model of delay discounting rate (k) and then log transformed (lnk).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eating Disorders

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adolescent girls between 12-16 years old

Parental history of eating pathology or no parental history of eating pathology

GE MR Scanner

Intervention Type DEVICE

3T GE MR 750 systems MR scanner

Scanners run compatible software so pulse sequences and reconstructions can easily be supported on all systems. Reconstruction servers are networked to all scanners for reconstruction and data archiving. 3T scanner is equipped with state-of-the-art gradient systems (at least 40 mT/m Gradients / 150 mT/m/ms slew rates) and 16 or more receive channels. 3T scanner includes an assortment of RF coils including quadrature and phased-array coils designed to image brain, spine, neurovascular, torso, pelvis, cardiac, knee, foot/ankle, and hand/wrist. 3T system has several sizes of 16-channel "wrap" coils that are excellent for scans using parallel imaging.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GE MR Scanner

3T GE MR 750 systems MR scanner

Scanners run compatible software so pulse sequences and reconstructions can easily be supported on all systems. Reconstruction servers are networked to all scanners for reconstruction and data archiving. 3T scanner is equipped with state-of-the-art gradient systems (at least 40 mT/m Gradients / 150 mT/m/ms slew rates) and 16 or more receive channels. 3T scanner includes an assortment of RF coils including quadrature and phased-array coils designed to image brain, spine, neurovascular, torso, pelvis, cardiac, knee, foot/ankle, and hand/wrist. 3T system has several sizes of 16-channel "wrap" coils that are excellent for scans using parallel imaging.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female
* Ages 12 - 16
* Must have biological parental history of AN or BN, or no history of psychiatric diagnoses

Exclusion Criteria

* Current diagnosis of an Eating Disorder;
* Symptoms of major psychiatric disorders (substance use disorders, conduct disorder, attention deficit hyperactive disorder, major depression, bipolar disorder, panic disorder, agoraphobia, generalized anxiety disorder);
* Serious medical conditions (diabetes, brain injury, cancer);
* Body Mass Index (BMI) \<17.5;
* Any contraindications for MRI (e.g. metal objects/implants in body, irremovable body piercings, tattoos or braces, medications that interfere with MRI, history of head injury with loss of consciousness, phobia that wouldn't allow them to complete the MRI);
* Current regular psychoactive drug use;
* Relevant food allergies;
* Not in age range
Minimum Eligible Age

12 Years

Maximum Eligible Age

16 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stanford University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Eric Stice

Professor of Psychiatry and Behavioral Sciences

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric Stice, PhD

Role: PRINCIPAL_INVESTIGATOR

Stanford University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Stanford University

Stanford, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

61869

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.